Matti Aapro

Lausanne

Editor In Chief, Critical Reviews in Oncology/Hematology and Associate Editor, at Cancer Investigation

Featured in: Favicon

tandfonline.com Favicon

thelancet.com Favicon

futuremedicine.com Favicon

emjreviews.com Favicon

ejcancer.com Favicon

touchoncology.com Favicon

onlinelibrary.wiley.com

Articles

Less talking. More doing. The current status of EU cancer policy

Jan 17, 2023 | touchoncology.com | Matti Aapro
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

Apr 19, 2022 | ejcancer.com | Matti Aapro
Implementing the European Code of Cancer Practice to Improve Europe’s Cancer Outcomes

Jul 14, 2021 | touchoncology.com | Matti Aapro
Iron deficiency in PREVENTT

Feb 18, 2021 | thelancet.com | Matti Aapro
Initiatives to Improve Control, Resource Use, and Quality of Life Associated with Chemotherapy-Induced Nausea and Vomiting

Aug 3, 2020 | emjreviews.com | Matti Aapro
The clinical training centers fellowships: a European School of Oncology career development program (2013-2019)

Jun 21, 2020 | futuremedicine.com | Nicholas Pavlidis |Matti Aapro
A new standard prophylaxis for emesis caused by cisplatin?

Mar 2, 2020 | thelancet.com | Matti Aapro
Comparison between oral and intravenous application of tranexamic acid for total hip arthroplasty: a meta-analysis

Mar 12, 2019 | futuremedicine.com | Matti Aapro
Preventing chemotherapy-induced nausea and vomiting with netupitant/palonosetron, the first fixed combination antiemetic: current and future perspective

Mar 12, 2019 | futuremedicine.com | Matti Aapro
Integration of oncology and palliative care: a Lancet Oncology Commission

Oct 18, 2018 | thelancet.com | Matti Aapro

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →